These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22211589)

  • 21. Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients.
    Bittar F; Rolain JM
    Clin Microbiol Infect; 2010 Jul; 16(7):809-20. PubMed ID: 20880410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F; Jonasson J
    Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Physiopathology of cystic fibrosis and of infections associated to this disease].
    Aramă SS; Aramă V; Cercel AS; Ion DA; Hristea A; Sotcan M
    Pneumologia; 2007; 56(4):202-7. PubMed ID: 18320796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody S60-4-14 reveals diagnostic potential in the identification of Pseudomonas aeruginosa in lung tissues of cystic fibrosis patients.
    Schmengler K; Goldmann T; Brade L; Sánchez Carballo PM; Albrecht S; Brade H; Kosma P; Sahly H; Hauber HP; Länger F; Meyer R; Welte T; Zähringer U
    Eur J Cell Biol; 2010 Jan; 89(1):25-33. PubMed ID: 20022136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.
    Mereghetti L; Marquet-van der Mee N; Loulergue J; Rolland JC; Audurier A
    Pathol Biol (Paris); 1998 May; 46(5):319-24. PubMed ID: 9769892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease.
    Döring G; Parameswaran IG; Murphy TF
    FEMS Microbiol Rev; 2011 Jan; 35(1):124-46. PubMed ID: 20584083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.
    Guss AM; Roeselers G; Newton IL; Young CR; Klepac-Ceraj V; Lory S; Cavanaugh CM
    ISME J; 2011 Jan; 5(1):20-9. PubMed ID: 20631810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas aeruginosa strains from the chronically infected cystic fibrosis lung display increased invasiveness of A549 epithelial cells over time.
    Harmer CJ; Triccas JA; Hu H; Rose B; Bye P; Elkins M; Manos J
    Microb Pathog; 2012 Jul; 53(1):37-43. PubMed ID: 22516803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of multiplex real-time PCR improves the detection of the bacterial etiology of community acquired pneumonia.
    Mustafa MI; Al-Marzooq F; How SH; Kuan YC; Ng TH
    Trop Biomed; 2011 Dec; 28(3):531-44. PubMed ID: 22433882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.
    Valenza G; Tappe D; Turnwald D; Frosch M; König C; Hebestreit H; Abele-Horn M
    J Cyst Fibros; 2008 Mar; 7(2):123-7. PubMed ID: 17693140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PCR and the detection of Pseudomonas aeruginosa in respiratory samples of CF patients. A literature review.
    Deschaght P; Van Daele S; De Baets F; Vaneechoutte M
    J Cyst Fibros; 2011 Sep; 10(5):293-7. PubMed ID: 21684819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intragenomic and intraspecific heterogeneity of the 16S rRNA gene in seven bacterial species from the respiratory tract of cystic fibrosis patients assessed by PCR-Temporal Temperature Gel Electrophoresis.
    Michon AL; Jumas-Bilak E; Imbert A; Aleyrangues L; Counil F; Chiron R; Marchandin H
    Pathol Biol (Paris); 2012 Jun; 60(3):e30-5. PubMed ID: 21621347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients.
    Martha B; Croisier D; Fanton A; Astruc K; Piroth L; Huet F; Chavanet P
    Clin Microbiol Infect; 2010 Jun; 16(6):617-23. PubMed ID: 20002106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients.
    Mounier J; Gouëllo A; Keravec M; Le Gal S; Pacini G; Debaets S; Nevez G; Rault G; Barbier G; Héry-Arnaud G
    J Microbiol; 2014 Apr; 52(4):307-14. PubMed ID: 24535743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR.
    Atkinson RM; Lipuma JJ; Rosenbluth DB; Dunne WM
    J Clin Microbiol; 2006 Mar; 44(3):833-6. PubMed ID: 16517862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis.
    da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G
    Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.
    Rogers GB; Skelton S; Serisier DJ; van der Gast CJ; Bruce KD
    J Clin Microbiol; 2010 Jan; 48(1):78-86. PubMed ID: 19906901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.